Google’s acquisition of Fitbit could pose ‘high level of risk to privacy and data protection’

Healthcare IT News | February 26, 2020

In a plenary session on February 20, concerns were raised about the privacy implications of a merger of obligations under the EU’s General Data Protection Regulation (GDPB). The Board urged both firms “to mitigate possible risks to the rights to privacy and data protection before notifying the merger to the European Commission”.It added that the EDPB will “consider any implications for the protection of personal data in the European Economic Area”.  Google and Fitbit did not respond to requests for comments from HIMSS Media. There have been questions around what will happen to Fitbit’s sensitive health and wellness data, since Google announced the acquisition in November last year.UK’s data watchdog, the Information Commissioner’s Office (ICO), and the US Department of Justice are both looking into privacy concerns around the deal. In a blog post about the acquisition, Google’s senior vice president of devices and services, Rick Osterloh, reassured consumers that “privacy and security are paramount

Spotlight

Three European Interventional Cardiologists, Prof. Colombo, Dr. Al-Shajlawi and Dr. Störger describe their experience with Drug Coated Balloon for coronary disease and comment on Agent, the Drug Coated Balloon with TransPax coating launched by Boston Scientific.

Spotlight

Three European Interventional Cardiologists, Prof. Colombo, Dr. Al-Shajlawi and Dr. Störger describe their experience with Drug Coated Balloon for coronary disease and comment on Agent, the Drug Coated Balloon with TransPax coating launched by Boston Scientific.

Related News

HEALTHTECH SECURITY,FUTURE OF HEALTHCARE

Sightpath Medical Acquires Accusite Surgical

Sightpath Medical | November 22, 2022

Sightpath Medical, the leading provider of mobile ophthalmic services for cataract and refractive surgery, announced that it has acquired Accusite Surgical, a cataract surgery equipment outsourcing company. Founded in 1991, Sightpath Medical delivers custom access to advanced ophthalmic equipment, instruments, and services to facilities and surgeons across the United States. Through its patented technology, the company was the first to mobilize phacoemulsification machines, excimer lasers, the IntraLase Femtosecond Laser, and the LenSx Femtosecond Laser. Sightpath Medical has earned the trust of medical professionals and patients nationwide through the quality of its equipment, the skill of its employees, and the dedication and responsiveness of its staff. Accusite Surgical is a mobile cataract surgical company that outsources state-of-the-art equipment, technology, and certified staff to surgeons, ambulatory surgical centers, and hospitals. For over 28 years, the company has assisted in more than 200,000 procedures throughout the Southeastern U.S. In connection with the transaction, D. Lynn Godfrey, Founder and Chief Executive Officer of Accusite Surgical, will join Sightpath Medical as Chief Strategy Officer. “This strategic combination bolsters Sightpath Medical’s market-leading position and enhances our ability to deliver variable, tailored access to the expert personnel, equipment, and supplies surgeons need to provide critical eye care. We are delighted to begin integrating the Accusite Surgical business into ours and are equally excited to welcome Lynn Godfrey, who is an experienced and creative executive, to our management team. We look forward to growing Sightpath Medical together.” Joel Gaslin, President and CEO of Sightpath Medical Mr. Godfrey added, “After 28 years, I began exploring the long-term options for my business and quickly determined that the Sightpath Medical executive team and its financial partner, MGG Investment Group, were the right partners for Accusite Surgical. We are closely aligned on our core mission of helping surgeons and their referring Optometrists provide patients with excellent eye care and, ultimately, better vision. I am thrilled to commence Accusite Surgical’s next chapter as part of Sightpath Medical.” About Sightpath Medical Sightpath Medical is the leading U.S. provider of mobile ophthalmic services for cataract, refractive and laser-assisted surgery. Working alongside more than 1,200 surgeons and the staffs of their surgical facilities for more than 30 years, Sightpath Medical is the market-leading choice for surgeons, ASCs, and hospitals due to our proven ability to deliver the staff, equipment, and supplies wherever and whenever they are needed – regardless of geography. About Accusite Surgical For nearly three decades, Accusite Surgical has been a leading provider of state-of-the-art equipment, supplies, and support for cataract surgery in the Southeastern United States. Accusite Surgical is a trusted partner to ASCs and hospitals and ophthalmologists for cataract surgery services and is committed to helping surgeons grow their practices while delivering superior outcomes for patients.

Read More

HEALTH TECHNOLOGY, MEDICAL DEVICES

Signify Health and Prospect Medical Holdings Team Up to Provide Top-notch Care

Signify Health | January 12, 2023

Signify Health, a top healthcare platform that uses advanced analytics, technology, and nationwide healthcare networks, announced a new partnership with Prospect Medical Holdings, Inc., a growing healthcare services company on January 11, 2023. The collaboration will help create and run value-based payment programs for superior care. To improve care transformation, manage risk, and provide high-quality, coordinated patient care for its traditional Medicare fee-for-service patients, Prospect's Waterbury HEALTH and Eastern Connecticut Health Network (ECHN) facilities and their affiliated provider network in Connecticut will join a Signify-enabled accountable care organization (ACO) in 2023 as part of the Medicare Shared Savings Program (MSSP). Signify Health will assist Prospect facilities in managing their MSSP ACO risk, lowering costs, and increasing quality incentives by providing data-driven, tailored population health roadmaps. Patients who seek treatment at Prospect's hospitals, which provide care to underprivileged and diverse populations across the state, will benefit from the strategic partnership. EJay Lockwood, Vice President, Connecticut Coordinated Care at Prospect Medical Holdings stated, "Every healthcare market is different to a certain extent, but we were impressed by Signify's experience that has spanned so many markets and has managed to 'stay local' while simultaneously honing their approach to delivering on the core competencies that any successful ACO needs to have." (Source: Business Wire) Tim Gronniger, Chief of Value-based Care Solutions, Signify Health, shared, "Prospect's Connecticut teams serve patients living in economically disadvantaged areas who also have been medically underserved. Through our work together, Prospect's Medicare patients will receive needed increased access to preventative and in-home services that will help improve their health outcomes, while creating a better overall experience for both patients and their care teams." (Source: Business Wire) About Signify Health At Signify Health, a renowned healthcare platform, cutting-edge analytics, technology, and national healthcare provider networks enable value-based payment options. Health plans and organizations use the company's technologies to assess risk and develop ways to enhance patient outcomes, coordination, and cost. Its platform coordinates clinical, social, and behavioral treatments. Signify Health meets customers' needs, reduces costs, and brings care closer to home.

Read More

HEALTHTECH SECURITY, INSURANCE

CrowdHealth Secures $6M Series A for Community-Powered Alternative to Health Insurance

CrowdHealth | December 12, 2022

CrowdHealth recently secured $6 million in Series A funding from Next Coast Ventures and Activate Venture Partners. CrowdHealth plans to reinvest that funding back into the company—growing the CrowdHealth community and providing more tools for members that want to take charge of their healthcare and affordably break free from health insurance. Operating under a monthly membership model, CrowdHealth is a health care technology company that offers a new way to use and pay for health care services outside of health insurance. CrowdHealth harnesses the power of crowdfunding to help their members fund medical bills, keeping them out of medical debt without being exploited by health insurance companies. Instead of paying a high premium for insurance companies to decide what is or isn't covered, CrowdHealth members make a monthly membership payment and others in the Crowd help fund medical bills from their own accounts. In addition to the low monthly membership and the increased autonomy of crowdfunding, CrowdHealth also makes Care Advocates available to members. Care Advocates can coordinate with doctors and hospitals to negotiate lower costs for medical bills on behalf of members which is a far departure from the health insurance model that has existed for decades. "Our health insurance system is broken. Health insurance is cold, oftentimes unreliable, and perversely incentivized. We're changing the game at CrowdHealth. Treating people like real people, like extensions to our family, supporting them in their health journey, and helping get their bills paid at a low cost." Andy Schoonover, CEO of CrowdHealth CrowdHealth also offers a Bitcoin investment option for members who are interested in harnessing the power of Bitcoin. This new innovation, launched in October 2022 in partnership with Swan Bitcoin, will allow members to redirect a portion of their monthly subscription payment to a Swan account. About CrowdHealth CrowdHealth provides people with an opportunity to take control of their healthcare choices. Members are able to combat and overcome the challenges of traditional healthcare models effectively without the need for insurance.

Read More